Back to Agenda
Session 8 – The Closing Plenary: Navigating the 2026 Life Sciences Geopolitical Landscape - Capital, Policy, and Global Markets
Session Chair(s)
Lawrence Tallon
Chief Executive Officer, Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Sahirzeeshan Ali
Founder and General Partner, Modi Ventures, United States
SESSION OVERVIEW:This closing plenary session examines the strategic forces shaping UK medicines R&D. Industry leaders will analyze current capital allocation, evolving UK regulatory frameworks, and geopolitical pressures.
SESSION IMPACT:The attendees will learn about capital flows and how there has been a scaling of public-private investments and infrastructure development in the UK over the last few years. We will also discuss the policy shifts, and the overarching impact of new MHRA reforms and national health plans. Finally, participants will be able to take away insights on the global market dynamics and hear discussions among experts on how they mitigate supply chain risks and continue to be successful in a world of intense international competition.
Have an account?